Clark Estates Inc. NY bought a new position in Maximus, Inc. (NYSE:MMS - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 27,138 shares of the health services provider's stock, valued at approximately $1,851,000.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Captrust Financial Advisors bought a new position in Maximus in the fourth quarter worth $276,000. GAMMA Investing LLC lifted its position in Maximus by 67.1% in the first quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock worth $50,000 after purchasing an additional 294 shares during the period. Blue Trust Inc. lifted its position in Maximus by 32.8% in the first quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider's stock worth $84,000 after purchasing an additional 303 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Maximus in the first quarter worth $2,115,000. Finally, Janney Montgomery Scott LLC raised its stake in Maximus by 70.5% during the first quarter. Janney Montgomery Scott LLC now owns 10,145 shares of the health services provider's stock worth $692,000 after acquiring an additional 4,196 shares in the last quarter. 97.21% of the stock is owned by institutional investors.
Insider Activity
In other news, Director Gayathri Rajan sold 7,913 shares of the company's stock in a transaction on Friday, May 30th. The stock was sold at an average price of $72.38, for a total transaction of $572,742.94. Following the transaction, the director owned 14,205 shares of the company's stock, valued at $1,028,157.90. This represents a 35.78% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 1.60% of the stock is owned by company insiders.
Maximus Price Performance
Maximus stock traded down $1.02 during mid-day trading on Friday, hitting $72.84. 509,770 shares of the company were exchanged, compared to its average volume of 422,065. The company has a quick ratio of 1.84, a current ratio of 1.84 and a debt-to-equity ratio of 0.87. The business has a fifty day moving average of $71.31 and a 200 day moving average of $70.55. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.94. The company has a market capitalization of $4.10 billion, a PE ratio of 14.48 and a beta of 0.61.
Maximus (NYSE:MMS - Get Free Report) last announced its earnings results on Thursday, May 8th. The health services provider reported $2.01 EPS for the quarter, topping the consensus estimate of $1.37 by $0.64. The company had revenue of $1.36 billion for the quarter, compared to analysts' expectations of $1.29 billion. Maximus had a return on equity of 23.37% and a net margin of 5.56%. The business's revenue for the quarter was up 1.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.57 earnings per share. As a group, sell-side analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current year.
Maximus Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Sunday, August 31st. Stockholders of record on Friday, August 15th will be paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.6%. The ex-dividend date of this dividend is Friday, August 15th. Maximus's dividend payout ratio is 23.86%.
Analysts Set New Price Targets
Separately, Wall Street Zen lowered Maximus from a "buy" rating to a "hold" rating in a research note on Thursday, May 15th.
Get Our Latest Stock Analysis on Maximus
About Maximus
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
See Also

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.